The browser you’re using is no longer supported by our website. Please use Microsoft Edge, Chrome or Firefox for a better browsing experience.

Board of Directors

The Board of Directors is committed to ensuring that Givaudan, as a Company, is headed in the right direction, in terms of strategy and management.

The Board of Directors is the highest strategic management body of Givaudan. It sets Givaudan’s strategy and the investment policy, ensures adequate operational and financial performance, manages succession planning and compensation and oversees Givaudan’s internal audit, compliance and risk management and general governance matters. By steering Givaudan's purpose and strategy, the Board of Directors is involved in setting the direction for sustainability matters, including targets.

Membership of the Board is composed in such a way as to ensure the Board possesses all competencies required to execute its strategic oversight and control over Givaudan. The Board’s knowledge and diversity of experience are important assets in leading a company of Givaudan’s size in a complex and fast-changing environment. Each of the current nine Board members has an in-depth knowledge of his or her relevant areas of expertise. As the Board considers ESG matters an integral part of Givaudan‘s strategy, familiarity with ESG matters is required from all Board members, as are strong ethical values.

MEET THE MEMBERS OF THE BOARD

The Board of Directors has four established Committees: an Audit Committee, a Nomination and Governance Committee, a Compensation Committee and an Innovation Committee. Each committee is led by a Committee Chairman whose main responsibilities are to organise, lead and minute the meetings.

According to Givaudan’s Articles of Incorporation, the Board of Directors may consist of between seven and nine members. The members of the Board of Directors are elected by the General Meeting of Shareholders and election is individual. The term of office of the Board members is one year, from one ordinary Annual General Meeting of Shareholders to the next one, subject to prior resignation or removal. Barring exceptional circumstances, Board members are not proposed for re-election at the ordinary general meeting following their 70th birthday. The Board regularly reviews the list of its competencies and has established a long-term skill matrix for the assessment of existing and required competencies which is used as a basis for Board succession planning.

Details on remuneration and ownership of securities can be found in our online integrated report.

Read more about the Board of Directors' remuneration and securities ownership

  
Committees of the Board

The Board has four Committees – the Audit Committee, the Nomination and Governance Committee, the Compensation Committee, and the Science and Innovation Committee. Each are led by a Committee Chairman whose main responsibilities are to organise, lead and minute the meetings.

List of members and role in each committee, from 24 March 2022

Audit

Nomination and governance

Compensation

Innovation

Calvin Grieder

• •

Werner Bauer

• •

Victor Balli

• •

• 

Lilian Biner

Michael Carlos

• •

Ingrid Deltenre

Olivier Filliol
Sophie Gasperment
Tom Knutzen

• • Chairman of the committee
 

The purpose and work of each committee
    

Audit Committee
The primary function of the Audit Committee is to assist the Board in fulfilling its oversight responsibilities by reviewing the financial information, the systems of internal controls and the audit process. It carries out certain preparatory work for the Board of Directors as a whole. The Audit Committee currently consists of four members of the Board. All of them have the requisite financial experience.

The Audit Committee ensures that the Company’s risk management systems are efficient and effective. It promotes effective communication among the Board, management, the internal audit function and external audit. It reviews and approves the compensation of the external auditors for the annual audit.  

Compensation Committee
The Compensation Committee reviews and recommends the compensation policies to the Board of Directors. It approves the remuneration of the Chief Executive Officer and the other members of the Executive Committee as well as all performance-related remuneration instruments and pension fund policies. Since the Swiss Ordinace against Excessive Compensation came into force, the Committee prepares the Compensation Report to be established by the Board.

The Compensation Committee consists of three members of the Board who are elected annually by the Annual General Meeting of shareholders. The Committee takes advice from external independent compensation specialists and consults with the Chairman and the Chief Executive Officer on specific matters where appropriate. Since the Annual General Meeting 2014, the members of the Compensation Committee are elected by the shareholders from the re-elected Board members.  

Nomination and Governance Committee
The Nomination and Governance Committee assists the Board in applying the principles of good corporate governance. It prepares appointments to the Board of Directors and the Executive Committee and advises on the succession planning process of the Company. It consists of four members of the Board.  

Innovation Committee
The Innovation Committee advises the Board on scientific matters relevant to the flavour and fragrance and cosmetics industry, or other additional fields the Board may request. It acts as a sounding board to the Board of Directors and research management, reviewing activities in different fields of research, looking at new opportunities and possible partnerships and reviewing projects on a detailed basis as required. It also serves as a platform for Board dialogue with the relevant members of the Executive Committee and the two heads of Science and Technology.

Meeting attendance

For the details on the number of meetings for each committee in 2021, and the attendance of each Board member to the different meetings please consult the Governance Report pages 11-13.

READ MORE IN THE GOVERNANCE REPORT